Executive Officer
 |
William E. Pullman, MB BS, BMedSc, PhD, FRACPExecutive Vice President, Chief Research & Development Officer
Dr. William E. Pullman has been at Dyax since October 2007 and serves as the Company’s Executive Vice President and Chief Research and Development Officer. In this position, Dr. Pullman is responsible for overseeing Research, Clinical Development, Regulatory Affairs, Medical Affairs and Technical Operations. Prior to working with Dyax, Dr. Pullman served as Senior Vice President and Chief Medical Officer at Cubist Pharmaceuticals. Previously, he served as Senior Vice President, Exploratory Development at Transform Pharmaceuticals. From 2001 to 2005, he filled various senior management positions at sanofi-aventis and from 1995 to 2001 held multiple director-level positions of increasing responsibility at Eli Lilly and Company. He began his career at Pfizer as a clinical pharmacologist. Prior to that, he was a practicing gastroenterologist. Dr. Pullman received his medical degree (MB BS) from the University of Western Australia and his PhD from Australian National University, and he is a Fellow of the Royal Australasian College of Physicians (FRACP). |